Loading...
Targeting non-small cell lung cancer: driver mutation beyond epidermal growth factor mutation and anaplastic lymphoma kinase fusion
The identification of driver mutations in epidermal growth factor receptor, anaplastic lymphoma kinase, the BRAF and ROS1 genes and subsequent successful clinical development of kinase inhibitors not only significantly improves clinical outcomes but also facilitates the discovery of other novel driv...
Saved in:
| Published in: | Ther Adv Med Oncol |
|---|---|
| Main Author: | |
| Format: | Artigo |
| Language: | Inglês |
| Published: |
SAGE Publications
2020
|
| Subjects: | |
| Online Access: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6984433/ https://ncbi.nlm.nih.gov/pubmed/32047535 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/1758835919895756 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|